Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Organovo Holdings Inc    

ORGANOVO HOLDINGS INC

 SummaryNewsRatingsCompany 
Company
Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including... 
More about the company
All news about ORGANOVO HOLDINGS INC
10/22MEDICINOVA : Appoints Carolyn Beaver to its Board of Directors and as Audit Comm..
AQ
09/21ORGANOVO : Submission of Matters to a Vote of Security Holders (form 8-K/A)
AQ
09/17ORGANOVO HOLDINGS, INC. : Change in Directors or Principal Officers, Submission ..
AQ
09/03ORGANOVO HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued ..
AQ
09/03Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement
GL
08/19ORGANOVO HOLDINGS, INC. : REVERSE SPLIT: 1 of 20
FA
08/17ORGANOVO HOLDINGS, INC. : Material Modification to Rights of Security Holders, A..
AQ
08/17Organovo Announces One-for-Twenty Reverse Stock Split
GL
08/12The Global 4D Printing Market to Garner $236.22 Billion by the year 2028
AQ
08/10ORGANOVO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
07/15ORGANOVO HOLDINGS, INC. : Entry into a Material Definitive Agreement, Change in ..
AQ
05/28ORGANOVO : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/20ORGANOVO HOLDINGS, INC. : Change in Directors or Principal Officers, Financial S..
AQ
04/08ORGANOVO HOLDINGS, INC. : Termination of a Material Definitive Agreement, Submis..
AQ
04/07ORGANOVO : Announces Termination of Merger Agreement with Tarveda Therapeutics
BU
More news
News in other languages on ORGANOVO HOLDINGS INC
2017ORGANOVO HOLDINGS INC : Veröffentlichung des Jahresergebnisses
2017ORGANOVO HOLDINGS INC : publication des résultats annuels
More news
Managers
NameTitle
Keith Murphy Executive Chairman & Chief Executive Officer
Christopher Heberlig President & Chief Financial Officer
Jeffrey N. Miner Chief Scientific Officer
Adam K. Stern Independent Director
Douglas Jay Cohen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORGANOVO HOLDINGS INC68
LONZA GROUP AG62.80%47 152
SEAGEN INC.72.54%34 263
IQVIA HOLDINGS INC.8.39%32 108
CELLTRION, INC.31.49%28 160
MODERNA, INC.260.58%27 830